Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.7314
+0.0091 (1.26%)
Sep 18, 2025, 2:29 PM EDT - Market open
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $56.21 million as of September 18, 2025. Its market cap has increased by 59.92% in one year.
Market Cap
56.21M
Enterprise Value
38.25M
1-Year Change
59.92%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $226.28M to $56.21M, a decrease of -75.16%. That is a compound annual growth rate of -16.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 55.51M | -19.62% |
| Dec 31, 2024 | 69.05M | -42.03% |
| Dec 29, 2023 | 119.13M | -2.89% |
| Dec 30, 2022 | 122.67M | -65.85% |
| Dec 31, 2021 | 359.22M | -5.17% |
| Dec 31, 2020 | 378.78M | 3.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |